Liver disease also affects pharmacokinetics of statins.
Rodighiero
V
V
Gaion
R M
RM
D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000493:pharmacokinetics*; D008107:Liver Diseases / Q000378:metabolism*
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors